Semprex-D (Page 4 of 4)
DOSAGE AND ADMINISTRATION
The recommended dosage for adults and adolescents 12 years and older is one capsule administered orally, every 4 to 6 hours four times a day.
HOW SUPPLIED
SEMPREX-D Capsules (dark green opaque cap and white opaque body with a yellow band) contain acrivastine 8 mg and pseudoephedrine hydrochloride 60 mg. The cap is printed with “404” in white ink, and the body is printed with “SEMPREX-D” in black ink.
NDC 53014-404-10 Bottle of 100’s
Storage
Store at 15° to 25° C (59° to 77° F) in a dry place and protected from light.
Keep out of the reach of children.
For Medical Information
Contact: Medical Affairs Department
Phone: (866) 822-0068
Fax: (770) 970-8859
Marketed by:
UCB, Inc.
Smyrna, GA 30080
Manufactured by:
DSM Pharmaceuticals, Inc.
Greenville, NC 27834 USA
SEMPREX is a registered trademark of UCB, Inc., Smyrna, GA 30080
© 2007, UCB, Inc., Smyrna, GA 30080
All rights reserved.
Rev. 1E 07/2007 003419
SEMPREX-D acrivastine and pseudoephedrine hydrochloride capsule | ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
| ||||||||||||||||||||||
Labeler — UCB, Inc. |
Revised: 05/2008 UCB, Inc.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.